Botanical species · safety record

Alliaria petiolata

The EFSA Compendium of Botanicals holds 17 constituent measurements for Alliaria petiolata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Alliaria petiolata (M.Bieb.) Cavara & Grande

17Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cyanide	Seed	Solvent extraction	108.9 ppm	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Cyanide	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Cyanide	Live plants	Solvent extraction	100 ppm	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Sinigrin	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Allyl isothiocyanate	Leaves	Essential oil	≥ 40.3 Percent	GC-MS	No resolvable identifier
Allyl isothiocyanate	Leaves	Essential oil	≤ 47.2 Percent	GC-MS	No resolvable identifier
Benzaldehyde	Leaves	Essential oil	≤ 1 Percent	GC-MS	No resolvable identifier
Benzaldehyde	Leaves	Essential oil	≥ 0.8 Percent	GC-MS	No resolvable identifier
Beta-ionone	Leaves	Essential oil	≤ 1.9 Percent	GC-MS	No resolvable identifier
Beta-ionone	Leaves	Essential oil	≥ 0.3 Percent	GC-MS	No resolvable identifier
Diallyl disulfide	Leaves	Essential oil	≥ 0.3 Percent	GC-MS	No resolvable identifier
Diallyl disulfide	Leaves	Essential oil	≤ 7.2 Percent	GC-MS	No resolvable identifier
Eugenol	Leaves	Essential oil	15.7 Percent	GC-MS	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Methyl salicylate	Leaves	Essential oil	4.6 Percent	GC-MS	No resolvable identifier
Nonanal	Leaves	Essential oil	≤ 3 Percent	GC-MS	No resolvable identifier
Phenylacetaldehyde	Leaves	Essential oil	≤ 2.8 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Blazevic, Ivica., Mastelic, Josip. Free and Bound Volatiles of Garlic Mustard (Alliaria petiolata). Croatica chemica acta, 2008, vol. 81, no. 4, p. 607-613.
Frisch, Tina., Motawia, Mohammed S., Olsen, Carl E., Agerbirk, Niels., Moller, Birger L., Bjarnholt, Nanna. Diversified glucosinolate metabolism: biosynthesis of hydrogen cyanide and of the hydroxynitrile glucoside alliarinoside in relation to sinigrin metabolism in Alliaria petiolata . Frontiers in plant science, 2015, vol. 6. DOI
Cipollini, Don., Gruner, Bill. Cyanide in the chemical arsenal of garlic mustard, Alliaria petiolata. Journal of chemical ecology, 2007, vol. 33, no. 1, p. 85-94. DOI
Bennett, Richard N., Mellon, Fred A., Kroon, Paul A. Screening crucifer seeds as sources of specific intact glucosinolates using ion-pair high-performance liquid chromatography negative ion electrospray mass spectrometry. Journal of agricultural and food chemistry, 2004, vol. 52, no. 3, p. 428-438.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature